To address this gap, our objective is to establish a more comprehensive and precise predictive model by collectively examining serum tumor markers, CT imaging features, and clinical attributes in NSCLC patients for forecasting EGFR gene mutations. The gene discussed is EGFR; the disease is neoplasm.